Skip to main content
. 2019 Dec 5;61(2):133–142. doi: 10.1194/jlr.RA119000142

Fig. 4.

Fig. 4.

Effect of TUG891 and LA on GLP-1 release from TBCs. Cultured mouse (A) and human (B) TBCs were untreated (control) or treated with TUG891 (10 μM) or LA (50 μM) in combination or after preincubation with AH7614 (100 μM). GLP-1 release from TBCs was determined by ELISA, as mentioned in the Material and Methods section. The histograms represent the results of independent experiments (n = 3). The difference between values was determined by one-way ANOVA, followed by LSD test. P < 0.05 was considered as statistically significant. *In comparison to LA; $In comparison to TUG891.